Загрузка...
Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors
BACKGROUND: Monoamine oxidase inhibitors (MAOIs) are being developed for major depressive disorder, Alzheimer’s, and Parkinson’s Disease. Newer MAOIs have minimal sensitivity to tyramine, but a key limitation for optimizing their development is that standards for in vivo monoamine oxidase-A (MAO-A)...
Сохранить в:
| Опубликовано в: : | Int J Neuropsychopharmacol |
|---|---|
| Главные авторы: | , , , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Oxford University Press
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4772270/ https://ncbi.nlm.nih.gov/pubmed/26316187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyv078 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|